In vivo prime editing of a metabolic liver disease in mice

Prime editing is a highly versatile CRISPR-based genome editing technology that works without DNA double-strand break formation. Despite rapid technological advances, in vivo application for the treatment of genetic diseases remains challenging. Here, we developed a size-reduced SpCas9 prime editor...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Sci Transl Med
Glavni autori: Böck, Desirée, Rothgangl, Tanja, Villiger, Lukas, Schmidheini, Lukas, Matsushita, Mai, Mathis, Nicolas, Ioannidi, Eleonora, Rimann, Nicole, Grisch-Chan, Hiu Man, Kreutzer, Susanne, Kontarakis, Zacharias, Kopf, Manfred, Thöny, Beat, Schwank, Gerald
Format: Artigo
Jezik:Inglês
Izdano: 2022
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7614134/
https://ncbi.nlm.nih.gov/pubmed/35294257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.abl9238
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items